Mucosal Botulism A Novel Neurotoxoid Vaccine Prevents

نویسندگان

  • Hiroshi Kiyono
  • Jerry R. McGhee
  • Kohtaro Fujihashi
  • Shunji Kozaki
  • David W. Pascual
  • Herman F. Staats
  • Ryoki Kobayashi
  • Tomoko Kohda
  • Kosuke Kataoka
  • Hideshi Ihara
چکیده

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A novel neurotoxoid vaccine prevents mucosal botulism.

The threat posed by botulism, classically a food- and waterborne disease with a high morbidity and mortality, has increased exponentially in an age of bioterrorism. Because botulinum neurotoxin (BoNT) could be easily disseminated by terrorists using an aerosol or could be used to contaminate the food or water supply, the Centers for Disease Control and Prevention and the National Institute of A...

متن کامل

Chitosan-based Nanoparticles in Mucosal Vaccine Delivery

Most infectious diseases are caused by pathogenic infiltrations from the mucosal tract. Nowadays, the use of vaccines has been widely investigated for the prevention of different infectious diseases, infertility, immune disorders, malignancies, and allergies. Broad-spectrum adjuvant substances have been studied for immune system stimulation with a greater efficiency against specific antigens. V...

متن کامل

Immunogenicity evaluation of rBoNT/E nanovaccine after mucosal administration

Objective(s): The Botulism syndrome is caused by types A to G of botulinum neurotoxins. The binding domains of these neurotoxins are immunogenic and considered as appropriate candidate vaccines. Due to the low immunogenicity of recombinant vaccines, there have been many studies on the use of biocompatible carriers such as chitosan nanoparticles for the delivery of these vaccines. The aim of thi...

متن کامل

Vaccines against Botulism

Botulinum neurotoxins (BoNT) cause the flaccid paralysis of botulism by inhibiting the release of acetylcholine from motor neurons. There are seven serotypes of BoNT (A-G), with limited therapies, and no FDA approved vaccine for botulism. An investigational formalin-inactivated penta-serotype-BoNT/A-E toxoid vaccine was used to vaccinate people who are at high risk of contracting botulism. Howe...

متن کامل

Modified IAI 00843 - 07 Version 2 1 2 A recombinant Holo - toxoid Vaccine against Botulism 3 4

Modified IAI00843-07 Version2 1 2 A recombinant Holo-toxoid Vaccine against Botulism 3 4 Christina L. Pier, William H. Tepp, Marite Bradshaw, Eric A. Johnson, Joseph 5 T. Barbieri, and Michael R. Baldwin*. 6 7 Food Research Institute, University of Wisconsin, Madison, Wisconsin and 8 Department of Microbiology and Molecular Genetics, Medical College of 9 Wisconsin, Milwaukee, Wisconsin. 10 11 *...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2005